久久久久免费_精品国产乱码久久久久久久软件_欧美一区亚洲一区_国产一区二区三区高清在线观看_欧美日在线观看_成人网av

Chelsea Therapeutics   
Chelsea Therapeutics International Ltd.是生技制藥公司，從事類風濕性關節炎、牛皮癬、癌癥及其它免疫系統混亂的治療用藥。該公司重點研究中的新藥CH-1504，則是一種口服型的消炎、抗癌藥物

 
Chelsea Therapeutics (Nasdaq:CHTP) is a biopharmaceutical development company that acquires and develops innovative products for the treatment of a variety of human diseases, including central nervous system disorders. Chelsea is currently pursuing FDA approval in the U.S. for Northera? (droxidopa), a novel, late-stage, orally-active therapeutic agent for the treatment of symptomatic neurogenic orthostatic hypotension in patients with primary autonomic failure.